Dualsystems Biotech partners with IBR Inc. to validate the workflow of the CaptiRec Technology
Dualsystems Biotech AG Press Release
Dualsystems Biotech partners with IBR Inc. to validate the workflow of the CaptiRec Technology
Schlieren, Switzerland, January 2014: – Dualsystems Biotech AG has announced it will collaborate with another Swiss laboratory, Institute for Biopharmaceutical Research (IBR Inc.) to validate the CaptiRec Triceps/Ligand Receptor Capture Technology. This technology is used to identify the Cell Membrane Receptors on Living Cells.
The partnership will combine the respective strengths of Dualsystems, a leading service provider for protein interaction at the cell membrane and IBR Inc., a GLP-compliant contract research organization specializing in cell-based assays
